EQS-News: Sartorius expands bio-circular product offering for more sustainable bioprocesses

14.01.26 11:34 Uhr

Werte in diesem Artikel
Aktien

197,20 EUR 0,60 EUR 0,31%

EQS-News: SARTORIUS AG / Key word(s): Sustainability
Sartorius expands bio-circular product offering for more sustainable bioprocesses (news with additional features)

14.01.2026 / 11:34 CET/CEST
The issuer is solely responsible for the content of this announcement.

Wer­bung


Göttingen, Germany | January 14, 2026

Sartorius expands bio-circular product offering for more sustainable bioprocesses
 
  • Further production hubs in Germany and Tunisia now certified by International Sustainability and Carbon Certification
  • Certified raw materials significantly reduce dependence on fossil-based plastics
  • Bio-circular filters and additional single-use fluid management technologies now available for biopharma manufacturers
  • Certified production network spans sites in Germany, Tunisia, France and the UK

Sartorius is expanding its bio-based product portfolio to support the biopharma industry’s push toward more sustainable manufacturing. With ISCC Plus certification now extended to its sites in Göttingen, Germany, and M’Hamdia, Tunisia, the company can use certified renewable raw materials in additional product lines, reducing the share of fossil-based plastics while ensuring full compatibility with existing bioprocesses.

ISCC Plus is a global standard for renewable and recycled raw materials that ensures transparent and traceable sourcing and compliance across the value chain based on a mass-balance system. At its Göttingen headquarters, Sartorius will produce the PFAS-free filter Sartopore Evo using ISCC Plus-certified materials. In M’Hamdia, selected Flexsafe bags will be manufactured with certified second generation feedstock. The use of ISCC Plus-certified materials enables a reduction of fossil-based compounds by around 70 percent in the Flexsafe film and by an average 40-60 percent in Sartopore Evo filters.

“Our biopharma customers aim to increase production output while delivering on ambitious sustainability goals. Sartorius’ single-use technologies and process intensification solutions have long helped biopharma manufacturers make their processes more efficient - increasing output and reducing environmental impact,” said René Fáber, Head of the Bioprocess Division and Member of the Executive Board at Sartorius. “By integrating ISCC Plus-certified materials into additional key product groups, we are offering more sustainable alternatives while ensuring full compatibility with existing workflows. This reflects our commitment to reducing fossil-based materials and advancing sustainability in biomanufacturing.”

Earlier in 2025, Sartorius achieved ISCC Plus certification for its sites in Aubagne, France, and Stonehouse, United Kingdom, covering its Ambr bioreactor vessels, Vivaflow filters, and selected Flexsafe bags for the manufacture of biopharmaceutical. The company plans to expand the use of certified renewable raw materials across its global production network.
A profile of Sartorius
Sartorius is a leading international partner to the biopharmaceutical research and manufacturing industries. The Lab Products & Services Division focuses on innovative laboratory instruments and consumables for research and quality assurance laboratories in pharmaceutical and biopharmaceutical companies as well as academic research institutions. The Bioprocess Solutions Division supports customers with a broad product portfolio focused on single-use solutions for the safer, faster, and more sustainable production of biotech drugs, vaccines, and cell and gene therapies. With around 60 production and sales locations worldwide, the Göttingen-based company has a strong global presence. Sartorius regularly supplements its portfolio with acquisitions of complementary technologies. In 2024, the company generated sales revenue of around 3.4 billion euros. More than 13,500 employees serve customers around the globe.

Visit our newsroom and follow us on LinkedIn.
Contact
Leona Malorny
Head of External Communications
+49 551 308 4067
leona.malorny@sartorius.com
 

Additional features:

File: Sartorius Filter Production in Göttingen, Germany
File: SAG Media Release ISCC Certification for Göttingen and M'hamdia


14.01.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: SARTORIUS AG
Otto-Brenner-Straße 20
37079 Göttingen
Germany
Phone: +49.(0)551-308.0
Fax: +49.(0)551-308.3289
E-mail: info@sartorius.com
Internet: www.sartorius.com
ISIN: DE0007165631, DE0007165607
WKN: 716563, 716560
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2259340

 
End of News EQS News Service

Wer­bung

2259340  14.01.2026 CET/CEST

Ausgewählte Hebelprodukte auf Sartorius

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Sartorius

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Sartorius AG Vz.

Wer­bung

Analysen zu Sartorius AG Vz.

DatumRatingAnalyst
13.01.2026Sartorius vz OutperformBernstein Research
12.01.2026Sartorius vz NeutralGoldman Sachs Group Inc.
09.01.2026Sartorius vz Sector PerformRBC Capital Markets
07.01.2026Sartorius vz OverweightBarclays Capital
17.12.2025Sartorius vz BuyDeutsche Bank AG
DatumRatingAnalyst
13.01.2026Sartorius vz OutperformBernstein Research
07.01.2026Sartorius vz OverweightBarclays Capital
17.12.2025Sartorius vz BuyDeutsche Bank AG
16.12.2025Sartorius vz OutperformBernstein Research
15.12.2025Sartorius vz OverweightJP Morgan Chase & Co.
DatumRatingAnalyst
12.01.2026Sartorius vz NeutralGoldman Sachs Group Inc.
09.01.2026Sartorius vz Sector PerformRBC Capital Markets
20.10.2025Sartorius vz NeutralGoldman Sachs Group Inc.
10.10.2025Sartorius vz NeutralUBS AG
08.10.2025Sartorius vz HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
29.01.2025Sartorius vz VerkaufenDZ BANK
28.01.2025Sartorius vz UnderperformBernstein Research
15.01.2025Sartorius vz UnderperformBernstein Research
06.01.2025Sartorius vz UnderperformBernstein Research
06.01.2025Sartorius vz UnderperformBernstein Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Sartorius AG Vz. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen